Jonathan C. Wadsley

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.

Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 03, 2026

Exercise Boosts the Immune System and Enhances Immunotherapy Responses in Pancreatic Cancer and Mesothelioma.

Exercise Boosts the Immune System and Enhances Immunotherapy Responses in Pancreatic Cancer and Mesothelioma.

Journal: Biomolecules

Published: February 13, 2026

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

Journal: ESMO open

Published: January 12, 2026

A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid Cancer.

A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: December 04, 2025

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP-1 Agonists and Thyroid Cancer.

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP-1 Agonists and Thyroid Cancer.

Journal: Clinical endocrinology

Published: November 21, 2025

Role of Post-operative Thyroglobulin in Predicting Disease-recurrence in Differentiated Thyroid Cancer.

Role of Post-operative Thyroglobulin in Predicting Disease-recurrence in Differentiated Thyroid Cancer.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 06, 2025

Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours.

Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours.

Journal: Endocrine oncology (Bristol, England)

Published: September 28, 2025

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 19, 2025

Iodine or Not for Low-risk Differentiated Thyroid Cancer: How Should We Implement the Findings into UK Practice? An Expert Consensus Opinion.

Iodine or Not for Low-risk Differentiated Thyroid Cancer: How Should We Implement the Findings into UK Practice? An Expert Consensus Opinion.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 02, 2025

Corrigendum to "Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey" [Heliyon Volume 9, Issue 3, March 2023, Article e13765].

Corrigendum to "Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey" [Heliyon Volume 9, Issue 3, March 2023, Article e13765].

Journal: Heliyon

Published: June 19, 2025

Progress in precision therapies for advanced cholangiocarcinoma: inhibitors of FGFR1-3.

Progress in precision therapies for advanced cholangiocarcinoma: inhibitors of FGFR1-3.

Journal: Journal of gastrointestinal oncology

Published: April 05, 2025

Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.

Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.

Journal: Journal of geriatric oncology

Published: March 26, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026